Javier Villadiego

12PUBLICATIONS
46CO-AUTHORS
Molecular targetsNeurogeneticsPharmaceutical delivery technologiesCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Sep 09, 2026
Neuroinflammatory and Motor Alterations in LRRK2*G2019S Transgenic Mice Without Enhanced Vulnerability to Aging or Chronic MPTP-Induced Nigrostriatal Neurodegeneration.

|Nov 13, 2025
Spp1 Appears to Be a Key Gene for Sporadic Obstructive Hydrocephalus in the Absence of AQP4.

Miriam Echevarría, Laura Hiraldo-González, José Luis Trillo-Contreras

|Jan 23, 2024
Cortistatin as a Novel Multimodal Therapy for the Treatment of Parkinson's Disease.

Ignacio Serrano-Martínez, Marta Pedreño, Julia Castillo-González

|Mar 29, 2023
Protection and Repair of the Nigrostriatal Pathway with Stem-Cell-Derived Carotid Body Glomus Cell Transplants in Chronic MPTP Parkinsonian Model.

Javier Villadiego, Ana B Muñoz-Manchado, Verónica Sobrino

|Jan 09, 2023
Full protection from SARS-CoV-2 brain infection and damage in susceptible transgenic mice conferred by MVA-CoV2-S vaccine candidate.

Javier Villadiego, Juan García-Arriaza, Reposo Ramírez-Lorca

|Apr 23, 2022
Cellular Distribution of Brain Aquaporins and Their Contribution to Cerebrospinal Fluid Homeostasis and Hydrocephalus.

José Luis Trillo-Contreras, Reposo Ramírez-Lorca, Javier Villadiego

Pageof 2

Frequent Collaborators

6 joint publications

Miriam Echevarría

4 joint publications

Juan José Toledo-Aral

3 joint publications

Reposo Ramírez-Lorca

2 joint publications

Ernesto García-Roldán